0
0
India is witnessing a dramatic increase in cardiac medication sales, highlighting the country’s expanding heart disease burden. According to data compiled from 17 leading pharmaceutical companies, the cardiac medication market grew by more than 50% between June 2021 and June 2025. Sales soared from ₹1,761 crore to ₹2,645 crore, with the sector exhibiting a consistent annual growth rate of 10.7%.
This growth outpaces sales of drugs for other health complications, including gastrointestinal problems, infections, and diabetes. Experts attribute this spike to a combination of greater disease prevalence, improved diagnostic capabilities, and evolving treatment guidelines.
-
Broader Definition of Hypertension: Recent medical guidelines have lowered the threshold for diagnosing hypertension. While levels above 130-140mmHg systolic were once considered high, readings above 120mmHg now trigger intervention—expanding the pool of people needing antihypertensive drugs.
-
: India’s increasing life expectancy has led to a larger aging population. Older adults are more susceptible to heart disease, further driving demand for cardiac medications.
-
Improved Awareness and Diagnostics: Growing public awareness, along with enhanced access to diagnostic tools, means more people are being detected and treated for heart-related issues.
-
: Heart care now goes beyond lipid-lowering medications (such as statins) to include drugs for heart failure and arrhythmias. These different classes of medications often work together and are frequently prescribed as combination therapies.
Doctors interviewed in the report emphasize how cardiovascular medications serve interconnected roles. For instance, anti-hypertensives lower blood pressure, reducing cardiac strain. Statins cut cholesterol and help prevent arterial blockages, while anti-anginals improve blood flow and alleviate chest pain from narrowed arteries. This multi-pronged approach is increasingly standard in cardiac care.
-
Cardiovascular Disease Prevalence: Cardiovascular diseases (CVDs) now account for 27% of all deaths in India, according to central government data.
-
Major Contributor to NCD Deaths: Overall, non-communicable diseases (NCDs) make up 63% of national mortality, underlining the scale of the heart disease challenge.
The visibility of heart attacks among public figures and younger individuals has focused attention on the multifactorial nature of heart health. Experts note that lifestyle choices, stress, and consumption habits all play significant roles. While the precise causes of sudden cardiac arrest may not always be clear, the consensus is that better management and awareness are necessary for prevention.
:
This news article is based on publicly available data and expert opinions as reported by ETHealthworld. It does not constitute medical advice. For personal health concerns or before starting or changing any medication, please consult a qualified healthcare professional1.
